Intra-arterial Recombinant Human Tenecteplase Tissue-type Plasminogen Activator (rhTNK-tPA) Thrombolysis for Acute Medium Vessel Occlusion

Clinical trial NCT07302854 · RECRUITING

Trial details

NCT number: NCT07302854
Sponsor: Xiang Luo
Status: RECRUITING
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Acute Ischemic Stroke Medium Vessel Occlusion

Start date: 2025-12-30
Primary completion: 2028-12-01
Enrollment: 382

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.